Two closely watched copyright cases over the songs “Blurred Lines” and “Stairway to Heaven,” both set for rulings next year by the Ninth Circuit, are quietly linked by a common question: What music can jurors actually hear?
Wilmer Cutler Pickering Hale and Dorr has opened its first new office since the merger between Wilmer Cutler and Hale and Dorr, eyeing growing opportunities in intellectual property on mainland China with a new outpost in Beijing.
Canadian generic drug makers are opting out of the country’s trailblazing efforts to supply developing countries with patented drugs, blaming excessive safeguards for patent holders under the new law, according to a published report.
Pfizer Inc. has sued China's State Administration for Industry and Commerce, alleging that the agency unfairly rejected its application for domestic trademark protection for blood-pressure drug Envacar.
High-tech rivals PCTEL and 3COM, which have been trading complaints in federal court in Northern California in a dispute over patented modem technology, have settled their lawsuits with a cross-licensing agreement, the two companies said.
In a setback for lobbyists who have fought the diversion of fees from the U.S. Patent and Trademark Office, U.S. lawmakers have voted to raise the fees charged by the USPTO but will still allow those funds to be spent elsewhere.
U.S. lawmakers have passed a funding bill that would create an "intellectual property czar" whose agency would oversee all IP-related government programs in the U.S. and abroad.
European Union governments have once again delayed voting on a proposal for a controversial law that opponents say would allow the patenting of software in Europe.
Townsend and Townsend and Crew has quietly settled a lawsuit that accused the California intellectual-property law firm of legal malpractice, breach of fiduciary duty and breach of contract over a decade of service.
Morrison & Foerster’s upstart IP venture group is expected to help generate significant new work for the general-practice firm, according to the group’s founders.
The U.S. Congress has passed a bill designed to shield private companies that collaborate with universities from legal challenges to their patents, a move that is likely to bolster biotech companies in particular.
The World Intellectual Property Organization (WIPO) has rejected a proposal by the U.S. to extend copyright protection for television and radio productions to cover webcasting on the internet in a revised broadcast treaty.
Pfizer Inc. withheld crucial scientific data that might have influenced the patent review board's decision to grant the drug maker a second patent for Lipitor, attorneys for Indian generics maker Ranbaxy Laboratories Ltd. argued at the opening of the closely watched trial over patent rights to the blockbuster anti-cholesterol drug.
Only a month after it was slapped with a similar lawsuit by the largest union in the U.S., several New York Teamsters unions have filed a separate class-action lawsuit against Swedish-U.K. drug maker AstraZenca over the way it handled the patent expiration on blockbuster heartburn drug Prilosec.
In a move likely to lead to a preliminary injunction order, a federal jury has found that three claims central to medical device maker Inverness Medical Innovations’ lawsuit against rival Acon Laboratories are valid.
Heads of the world’s top three patent offices have agreed to speed up efforts to harmonize key features.
General-practice firm Sutherland Asbill & Brennan has snatched a group of intellectual property litigators from the Northern Virginia office of Pillsbury Winthrop.
A venture capital firm headed by former Microsoft executives is buying patents that could pose legal threats to its powerful high-tech investors, according to a published report.
Two decades after Sterne, Kessler, Goldstein & Fox helped pioneer the biotech intellectual property practice, the Washington, D.C.-based specialist firm has set its sights on nanotechnology as one of the most promising fields of the future.
In a preliminary decision, the U.S. International Trade Commission has cleared semiconductor packaging company Carsem of infringing patents held by rival Amkor Technology, Inc.
General-practice firm Morrison & Foerster has launched a new group that will help evaluate the intellectual property of upstart life-sciences companies for venture capitalists.